ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

CCOP Q&A, List Of Research Bases

September 10, 1982

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

NIH Director Collins Challenged On Capitol Hill Over NCI-Funded Research Linking Tea Party With Tobacco Companies

March 8, 2013

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals

September 7, 1979